US 7358390
Polymorphic forms of nateglinide
granted A61KA61K31/198
Quick answer
US patent 7358390 (Polymorphic forms of nateglinide) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/198